ChartSpan Acquires Validic to Expand Remote Patient Monitoring Platform

June 23, 2026
ChartSpan has completed the acquisition of Validic, integrating Validic’s health data technology with ChartSpan’s care management services to create a unified platform for continuous patient monitoring and proactive clinical care.

ChartSpan has completed its acquisition of Validic, combining ChartSpan’s care management services with Validic’s personal health data platform according to a press release. The unified company will deliver integrated clinical services, remote monitoring, and technology infrastructure to healthcare clients.

With Validic’s team and technology now part of ChartSpan, the company will support programs such as Chronic Care Management, Advanced Primary Care Management, and Remote Patient Monitoring. The combined platform will enable continuous patient visibility, allowing healthcare providers to identify risks earlier and take proactive action.

The acquisition expands ChartSpan’s offerings to include Validic’s health data API infrastructure, remote monitoring software, and device logistics capabilities. This broader portfolio will serve health systems, digital health companies, payers, and life sciences organizations seeking connected care solutions.

ChartSpan stated that the integration of Validic’s data infrastructure with its clinical services will help healthcare organizations reduce costs and improve outcomes through continuous patient insight and early intervention.

We hope you enjoyed this article.

Subscribe to AI Funding Brief

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more